Another protein marker assay tests for invasion and metastasis markers urokinase-type plasminogen activator (uPA)/plasminogen activator inhibitor-1 (PAI-1), using enzyme-linked immunosorbent assay (ELISA) to guide treatment in node-negative (N0) breast cancer. Here, SERPINE1 is linked to breast cancer.